0001842952-24-000018.txt : 20240322 0001842952-24-000018.hdr.sgml : 20240322 20240322080146 ACCESSION NUMBER: 0001842952-24-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240321 FILED AS OF DATE: 20240322 DATE AS OF CHANGE: 20240322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levit Alex C. CENTRAL INDEX KEY: 0001862840 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40654 FILM NUMBER: 24773138 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863738787 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 4 1 wk-form4_1711108898.xml FORM 4 X0508 4 2024-03-21 0 0001842952 Context Therapeutics Inc. CNTX 0001862840 Levit Alex C. 2001 MARKET STREET SUITE 3915, UNIT #15 PHILADELPHIA PA 19103 0 1 0 0 Chief Legal Officer, Corp. Sec 0 Stock Option (right to buy) 1.07 2024-03-21 4 A 0 153515 0 A 2034-03-20 Common Stock 153515 153515 D The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer. /s/ Alex Levit, Attorney-in-Fact 2024-03-22